API reference
Orlistat
- CAS number
- 96829-58-2
- Molecular formula
- C29H53NO5
- Molecular weight
- 495.7 g/mol
About this molecule
The global prevalence of obesity is increasing rapidly. Obesity-related complications lead to significant personal and economic burden by reducing quality of life and increasing the cost of healthcare. In some individuals, diet and exercise are insufficient to maintain weight loss, and pharmacological or surgical intervention is required. Orlistat is a lipase inhibitor used in the treatment of obesity that works by inhibiting fat-metabolizing enzymes. It was approved by the FDA for use in combination with a reduced-calorie diet in 1999. This drug is a generally well-tolerated and effective weight-loss aid and is now available in both over-the-counter and prescription preparations, depending on the dosage quantity.
Source: DrugBank, via PubChem.
Identifiers
- IUPAC name
- [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate
- InChIKey
- AHLBNYSZXLDEJQ-FWEHEUNISA-N
- SMILES
- CCCCCCCCCCC[C@@H](C[C@H]1[C@@H](C(=O)O1)CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
- Other CAS numbers recorded
- 104872-04-0
- PubChem CID
- 3034010
Also known as
orlistat · Tetrahydrolipstatin · Xenical · Orlipastat · Alli · (-)-Tetrahydrolipstatin · THLP · tetrahydrolipastatin
Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.
Tell us the grade, the quantity and the market.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.